MedaSystems, a Menlo Park, CA-based developer of a purpose-built pharma-physician network, raised an undisclosed amount in Seed funding.
Participants included
- Young Sohn, a founder of Veeva Systems, Vlocity, and Nomadic Systems;
- nina.capital, a specialist healthtech venture capital fund based in Barcelona; and
- members of the management team.
The company intends to use the funds to support real-world data capture, automation, and machine learning capabilities.
Led by Fiona Smythe, CEO, MedaSystems provides a SaaS platform that streamlines collaboration between medical affairs, clinical operations, regulatory and shipping teams internally, and physicians and their staff, externally, enabling the rapid processing of treatment inquiries and capture of real-world data.
For sponsors (pharmaceutical manufacturers), the platform enables the capture of real-world data which speeds drug discovery, expedites regulatory submission and informs the design of more effective clinical trials. Users can create forms to capture de-identified, real-world data. The data architecture and workflow means that sponsors can run a variety of programs on the platform, from Expanded or Managed Access to Post-Trial Access programs and Investigator Initiated Study requests, supporting all aspects of patient treatment outside of Clinical Trials. In addition, the platform provides visibility by allowing physicians to work with their staff and pharmacists, to understand where inquiries stand, the ability to request treatment and provide treatment updates.
FinSMEs
12/10/2023